|
|
| | Benzoic acid, 4-[(2R,4R)-1-[(7-cyclopropyl-5-methoxy-1H-indol-4-yl)methyl]-4-ethoxy-2-piperidinyl]-, rel- Basic information |
| | Benzoic acid, 4-[(2R,4R)-1-[(7-cyclopropyl-5-methoxy-1H-indol-4-yl)methyl]-4-ethoxy-2-piperidinyl]-, rel- Chemical Properties |
| Boiling point | 634.9±55.0 °C(Predicted) | | density | 1.28±0.1 g/cm3(Predicted) | | pka | 4.07±0.10(Predicted) |
| | Benzoic acid, 4-[(2R,4R)-1-[(7-cyclopropyl-5-methoxy-1H-indol-4-yl)methyl]-4-ethoxy-2-piperidinyl]-, rel- Usage And Synthesis |
| Uses | Factor B-IN-4 (Example 13 target compound) is a potent complement factor B inhibitor, with an IC50 of 1 μM. Factor B-IN-4 can be used for the research of diseases related to inflammation and immunity[1]. | | References | [1] Luan Linbo, et al. Heterocyclic compound, preparation method therefor and use thereof. WO2022028507A1. |
| | Benzoic acid, 4-[(2R,4R)-1-[(7-cyclopropyl-5-methoxy-1H-indol-4-yl)methyl]-4-ethoxy-2-piperidinyl]-, rel- Preparation Products And Raw materials |
|